**About the Editors**

#### **Andrzej Kutner**

Andrzej Kutner received his PhD in chemistry in 1982 and his DSc (habilitation) in pharmaceutical sciences in 1994, and in 2011 he was awarded the title of professor of pharmaceutical sciences. He has been a trainee at US universities (University of Wisconsin-Madison, New York University, University of Minnesota, Duluth, University of California, Riverside). He works at the Faculty of Pharmacy of the Medical University of Warsaw and lectures on pharmaceutical syntheses at the Chemistry Department of the University of Warsaw. The main area of interest is medicinal chemistry, synthesis of active substances, and analysis of the correlation between biological activity and molecular structure.

#### **Geoffrey Brown**

Geoffrey Brown received a BSc from Queen Elizabeth College, London, and a PhD from University College (with Prof Sir Mel Greaves), London. Postdoctoral research was at the MRC Immunochemistry Unit (with Alan Williams and Prof Rodney Porter) and the Nuffield Department of Clinical Medicine (in Prof Sir David Weatherall's Department), Oxford, where he was also IBM Fellow, University of Oxford and Research Lecturer, Christ Church College. He is now Reader in Cellular Immunology (Honorary), College of Medical and Dental Sciences, University of Birmingham. His research concerns the development of blood cells and the nature of leukemia stem cells.

#### **Enik ¨o Kallay**

Eniko Kallay received her PhD in biochemistry in 1999 at the University of Vienna and her ¨ habilitation in experimental pathophysiology in 2004 at the Medical University of Vienna. She has been a trainee at several US universities (Harward Medical School, John Hopkins University, MD, Strang Cancer Prevention Center, Cornell University, NY) and was a Marie Curie European Research Fellow at University of Oxford, UK. She works at the Dept. Pathophysiology and Allergy Research, Center of Pathophysiology, Infectiology and Immunology, Medical University of Vienna and lectures on cancer biology at the Karl Landsteiner University of Health Sciences, Krems, Austria. Her main area of interest is to unveil the biochemical and molecular mechanisms of the anti-tumourigenic and anti-inflammatory effects of vitamin D and dietary calcium in inflammatory bowel diseases and in cancers of the colon and ovaries.
